Modulation of NRF2 signaling pathway by nuclear receptors: Implications for cancer

被引:162
作者
Namani, Akhileshwar [1 ]
Li, Yulong [1 ]
Wang, Xiu Jun [2 ]
Tang, Xiuwen [1 ]
机构
[1] Zhejiang Univ, Sch Med, Dept Biochem & Genet, Hangzhou 310058, PR, Peoples R China
[2] Zhejiang Univ, Sch Med, Dept Pharmacol, Hangzhou 310058, PR, Peoples R China
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 2014年 / 1843卷 / 09期
关键词
NRF2; KEAP1; Nuclear receptor; Neh7; Cancer therapy; ANTIOXIDANT RESPONSE ELEMENT; TRANSCRIPTION FACTOR NRF2; UNION-OF-PHARMACOLOGY; CELL LUNG-CANCER; MESSENGER-RNA EXPRESSION; RETINOID-X-RECEPTORS; SMALL MAF PROTEINS; GENE-EXPRESSION; KEAP1; GENE; ERR-BETA;
D O I
10.1016/j.bbamcr.2014.05.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Nuclear factor-erythroid 2 p45-related factor 2 (NRF2, also known as Nfe212) plays a critical role in regulating cellular defense against electrophilic and oxidative stress by activating the expression of an array of antioxidant response element-dependent genes. On one hand, NRF2 activators have been used in clinical trials for cancer prevention and the treatment of diseases associated with oxidative stress; on the other hand, constitutive activation of NRF2 in many types of tumors contributes to the survival and growth of cancer cells, as well as resistance to anticancer therapy. In this review, we provide an overview of the NRF2 signaling pathway and discuss its role in carcinogenesis. We also introduce the inhibition of NRF2 by nuclear receptors. Further, we address the biological significance of regulation of the NRF2 signaling pathway by nuclear receptors in health and disease. Finally, we discuss the possible impact of NRF2 inhibition by nuclear receptors on cancer therapy. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:1875 / 1885
页数:11
相关论文
共 158 条
[1]
PPARγ signaling and metabolism: the good, the bad and the future [J].
Ahmadian, Maryam ;
Suh, Jae Myoung ;
Hah, Nasun ;
Liddle, Christopher ;
Atkins, Annette R. ;
Downes, Michael ;
Evans, Ronald M. .
NATURE MEDICINE, 2013, 19 (05) :557-566
[2]
CHROMOSOMAL LOCALIZATION OF THE HUMAN RETINOID-X RECEPTORS [J].
ALMASAN, A ;
MANGELSDORF, DJ ;
ONG, ES ;
WAHL, GM ;
EVANS, RM .
GENOMICS, 1994, 20 (03) :397-403
[3]
RAR and RXR modulation in cancer and metabolic disease [J].
Altucci, Lucia ;
Leibowitz, Mark D. ;
Ogilvie, Kathleen M. ;
de Lera, Angel R. ;
Gronemeyer, Hinrich .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (10) :793-810
[4]
Amann PM, 2011, CURR MED CHEM, V18, P1405
[5]
[Anonymous], 2006, J CARCINOG, DOI DOI 10.1186/1477-3163-5-14
[6]
Repression of cancer protective genes by 17β-estradiol:: Ligand-dependent interaction between human Nrf2 and estrogen receptor α [J].
Ansell, PJ ;
Lo, SC ;
Newton, LG ;
Espinosa-Nicholas, C ;
Zhang, DD ;
Liu, JH ;
Hannink, M ;
Lubahn, DB .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2005, 243 (1-2) :27-34
[7]
In vitro and in vivo regulation of antioxidant response element-dependent gene expression by estrogens [J].
Ansell, PJ ;
Espinosa-Nicholas, C ;
Curran, EM ;
Judy, BM ;
Philips, BJ ;
Hannink, M ;
Lubahn, DB .
ENDOCRINOLOGY, 2004, 145 (01) :311-317
[8]
Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust [J].
Aoki, Y ;
Sato, H ;
Nishimura, N ;
Takahashi, S ;
Itoh, K ;
Yamamoto, M .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2001, 173 (03) :154-160
[9]
Phosphorylation of nrf2 in the transcription activation domain by casein kinase 2 (CK2) is critical for the nuclear translocation and transcription activation function of Nrf2 in IMR-32 neuroblastoma cells [J].
Apopa, Patrick L. ;
He, Xiaoqing ;
Ma, Qiang .
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2008, 22 (01) :63-76
[10]
Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity [J].
Arlt, A. ;
Sebens, S. ;
Krebs, S. ;
Geismann, C. ;
Grossmann, M. ;
Kruse, M-L ;
Schreiber, S. ;
Schaefer, H. .
ONCOGENE, 2013, 32 (40) :4825-4835